Safety and efficacy of short-term (1 to 3 months) dual antiplatelet therapy in patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials

MLA

Timothy F. Simpson, et al. “Safety and Efficacy of Short-Term (1 to 3 Months) Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Interventions: A Meta-Analysis of Randomized Controlled Trials.” Journal of Thrombosis and Thrombolysis, vol. 50, June 2020, pp. 867–73. EBSCOhost, https://doi.org/10.1007/s11239-020-02069-9.

APA

Timothy F. Simpson, Mohammed Osman, Kris Kumar, Firas Zahr, Babikir Kheiri, Hind Rahmouni, Joaquin E. Cigarroa, Qais Radaideh, Punag Divanji, & Harsh Golwala. (2020). Safety and efficacy of short-term (1 to 3 months) dual antiplatelet therapy in patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials. Journal of Thrombosis and Thrombolysis, 50, 867–873. https://doi.org/10.1007/s11239-020-02069-9

Chicago

Timothy F. Simpson, Mohammed Osman, Kris Kumar, Firas Zahr, Babikir Kheiri, Hind Rahmouni, Joaquin E. Cigarroa, Qais Radaideh, Punag Divanji, and Harsh Golwala. 2020. “Safety and Efficacy of Short-Term (1 to 3 Months) Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Interventions: A Meta-Analysis of Randomized Controlled Trials.” Journal of Thrombosis and Thrombolysis 50 (June): 867–73. doi:10.1007/s11239-020-02069-9.